Should the Splenic Vein Be Preserved—Fate of Sinistral Portal Hypertension after Pancreatoduodenectomy with Vascular Re-Section for Pancreatic Cancer

Background: This study aims to evaluate sinistral portal hypertension (SPH) development and its clinical impact on the long-term outcomes of patients with pancreatic cancer who underwent surgical resection with splenic vein (SV) ligation. Methods: Data from 94 consecutive patients who underwent panc...

Full description

Bibliographic Details
Main Authors: Sung Hyun Kim, Seung-Seob Kim, Ho Kyoung Hwang, Woo Jung Lee, Chang Moo Kang
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/19/4853
_version_ 1797480138632331264
author Sung Hyun Kim
Seung-Seob Kim
Ho Kyoung Hwang
Woo Jung Lee
Chang Moo Kang
author_facet Sung Hyun Kim
Seung-Seob Kim
Ho Kyoung Hwang
Woo Jung Lee
Chang Moo Kang
author_sort Sung Hyun Kim
collection DOAJ
description Background: This study aims to evaluate sinistral portal hypertension (SPH) development and its clinical impact on the long-term outcomes of patients with pancreatic cancer who underwent surgical resection with splenic vein (SV) ligation. Methods: Data from 94 consecutive patients who underwent pancreatoduodenectomy (PD) with vascular resection for pancreatic cancer from 2008 to 2019 were retrospectively collected. The patients were divided into two groups according to whether the SV was preserved or ligated during the surgery. Their computed tomography images were serially reviewed (preoperative, 6-, 12-, and 24-months postoperative) with clinical parameters. The degree of variceal formation (variceal score) and splenomegaly were assessed, and the oncologic outcomes were compared between the two groups. Variceal score in the SV ligation group was significantly higher than that in the SV saving group at the same postoperative periods (SV saving vs. ligation: 12 months, 0.9 ± 1.3 vs. 3.5 ± 2.2, <i>p</i> < 0.001; 24 months, 1.4 ± 1.8 vs. 4.0 ± 3.4, <i>p</i> = 0.009). Clinically relevant variceal bleeding was noted in one patient from the SV ligation group (SV saving vs. ligation: 0.0% vs. 3.1%, <i>p</i> = 0.953). In survival analysis, there was no significant difference between the two groups (DFS; SV saving vs. ligation: 13.0 (11.1–14.9) months vs. 13.0 (10.4–15.6) months, <i>p</i> = 0.969, OS; SV saving vs. ligation: 35.0 (19.9–50.1) months vs. 27.0 (11.6–42.4) months, <i>p</i> = 0.417). Although SV ligation induced SPH during PD for pancreatic cancer, it did not lead to clinically significant long-term complications. In addition, it did not impact the long-term survival of patients with resected pancreatic head cancer.
first_indexed 2024-03-09T21:55:30Z
format Article
id doaj.art-2c4214b402f34d1ba84d0e3b15741378
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-09T21:55:30Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-2c4214b402f34d1ba84d0e3b157413782023-11-23T19:57:42ZengMDPI AGCancers2072-66942022-10-011419485310.3390/cancers14194853Should the Splenic Vein Be Preserved—Fate of Sinistral Portal Hypertension after Pancreatoduodenectomy with Vascular Re-Section for Pancreatic CancerSung Hyun Kim0Seung-Seob Kim1Ho Kyoung Hwang2Woo Jung Lee3Chang Moo Kang4Department of Hepatobiliary and Pancreatic Surgery, Yonsei University College of Medicine, Seoul 03722, KoreaPancreaticobiliary Cancer Center, Yonsei Cancer Center, Severance Hospital, Seoul 03722, KoreaDepartment of Hepatobiliary and Pancreatic Surgery, Yonsei University College of Medicine, Seoul 03722, KoreaDepartment of Hepatobiliary and Pancreatic Surgery, Yonsei University College of Medicine, Seoul 03722, KoreaDepartment of Hepatobiliary and Pancreatic Surgery, Yonsei University College of Medicine, Seoul 03722, KoreaBackground: This study aims to evaluate sinistral portal hypertension (SPH) development and its clinical impact on the long-term outcomes of patients with pancreatic cancer who underwent surgical resection with splenic vein (SV) ligation. Methods: Data from 94 consecutive patients who underwent pancreatoduodenectomy (PD) with vascular resection for pancreatic cancer from 2008 to 2019 were retrospectively collected. The patients were divided into two groups according to whether the SV was preserved or ligated during the surgery. Their computed tomography images were serially reviewed (preoperative, 6-, 12-, and 24-months postoperative) with clinical parameters. The degree of variceal formation (variceal score) and splenomegaly were assessed, and the oncologic outcomes were compared between the two groups. Variceal score in the SV ligation group was significantly higher than that in the SV saving group at the same postoperative periods (SV saving vs. ligation: 12 months, 0.9 ± 1.3 vs. 3.5 ± 2.2, <i>p</i> < 0.001; 24 months, 1.4 ± 1.8 vs. 4.0 ± 3.4, <i>p</i> = 0.009). Clinically relevant variceal bleeding was noted in one patient from the SV ligation group (SV saving vs. ligation: 0.0% vs. 3.1%, <i>p</i> = 0.953). In survival analysis, there was no significant difference between the two groups (DFS; SV saving vs. ligation: 13.0 (11.1–14.9) months vs. 13.0 (10.4–15.6) months, <i>p</i> = 0.969, OS; SV saving vs. ligation: 35.0 (19.9–50.1) months vs. 27.0 (11.6–42.4) months, <i>p</i> = 0.417). Although SV ligation induced SPH during PD for pancreatic cancer, it did not lead to clinically significant long-term complications. In addition, it did not impact the long-term survival of patients with resected pancreatic head cancer.https://www.mdpi.com/2072-6694/14/19/4853pancreatic cancersinistral portal hypertensionsplenic vein ligationsurvivalvarices
spellingShingle Sung Hyun Kim
Seung-Seob Kim
Ho Kyoung Hwang
Woo Jung Lee
Chang Moo Kang
Should the Splenic Vein Be Preserved—Fate of Sinistral Portal Hypertension after Pancreatoduodenectomy with Vascular Re-Section for Pancreatic Cancer
Cancers
pancreatic cancer
sinistral portal hypertension
splenic vein ligation
survival
varices
title Should the Splenic Vein Be Preserved—Fate of Sinistral Portal Hypertension after Pancreatoduodenectomy with Vascular Re-Section for Pancreatic Cancer
title_full Should the Splenic Vein Be Preserved—Fate of Sinistral Portal Hypertension after Pancreatoduodenectomy with Vascular Re-Section for Pancreatic Cancer
title_fullStr Should the Splenic Vein Be Preserved—Fate of Sinistral Portal Hypertension after Pancreatoduodenectomy with Vascular Re-Section for Pancreatic Cancer
title_full_unstemmed Should the Splenic Vein Be Preserved—Fate of Sinistral Portal Hypertension after Pancreatoduodenectomy with Vascular Re-Section for Pancreatic Cancer
title_short Should the Splenic Vein Be Preserved—Fate of Sinistral Portal Hypertension after Pancreatoduodenectomy with Vascular Re-Section for Pancreatic Cancer
title_sort should the splenic vein be preserved fate of sinistral portal hypertension after pancreatoduodenectomy with vascular re section for pancreatic cancer
topic pancreatic cancer
sinistral portal hypertension
splenic vein ligation
survival
varices
url https://www.mdpi.com/2072-6694/14/19/4853
work_keys_str_mv AT sunghyunkim shouldthesplenicveinbepreservedfateofsinistralportalhypertensionafterpancreatoduodenectomywithvascularresectionforpancreaticcancer
AT seungseobkim shouldthesplenicveinbepreservedfateofsinistralportalhypertensionafterpancreatoduodenectomywithvascularresectionforpancreaticcancer
AT hokyounghwang shouldthesplenicveinbepreservedfateofsinistralportalhypertensionafterpancreatoduodenectomywithvascularresectionforpancreaticcancer
AT woojunglee shouldthesplenicveinbepreservedfateofsinistralportalhypertensionafterpancreatoduodenectomywithvascularresectionforpancreaticcancer
AT changmookang shouldthesplenicveinbepreservedfateofsinistralportalhypertensionafterpancreatoduodenectomywithvascularresectionforpancreaticcancer